Skip to content
S5E04: Engineering Therapeutic Antibodies episode artwork

Jun 26, 2024 29 min

S5E04: Engineering Therapeutic Antibodies

from Two Scientists Walk Into a Bar Hosted by Genentech

Antibodies are proteins produced by our immune system that neutralize or help destroy abnormal cells and foreign agents, like bacteria and viruses. However, their utility extends beyond our bodies’ defense system. Antibodies can also be engineered in the lab to be used as therapies. Today, over 170 antibodies have been approved as medicines to treat a wide range of diseases including cancers, autoimmune diseases, infectious diseases and more. In this episode, co-host Maria Wilson chats with guests Yan Wu, VP and Senior Fellow, Antibody Engineering, and Paul Carter, Genentech Fellow, Antibody Engineering, to discuss all things antibodies! Learn about the history of therapeutic antibodies, how advances in antibody engineering are creating new classes of medicines, and the promising role of artificial intelligence in designing antibodies from scratch and optimizing their therapeutic activity. Read the full text transcript at www.gene.com/stories/engineering-therapeutic-antibodies

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

S5E04: Engineering Therapeutic Antibodies

0:00 29:27

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Two Scientists Walk Into a Bar?

This episode is 29 minutes long.

When was this Two Scientists Walk Into a Bar episode published?

This episode was published on June 26, 2024.

Can I download this Two Scientists Walk Into a Bar episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.